These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11882746)

  • 1. H2 histamine receptor blockade in the treatment of Alzheimer disease: a randomized, double-blind, placebo-controlled trial of nizatidine.
    Carlson MC; Tschanz JT; Norton MC; Welsh-Bohmer K; Martin BK; Breitner JC
    Alzheimer Dis Assoc Disord; 2002; 16(1):24-30. PubMed ID: 11882746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Weight gain management in patients with schizophrenia during treatment with olanzapine in association with nizatidine.
    Assunção SS; Ruschel SI; Rosa Lde C; Campos JA; Alves MJ; Bracco OL; de Lima MS
    Braz J Psychiatry; 2006 Dec; 28(4):270-6. PubMed ID: 17242805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind, placebo-controlled study of the effectiveness and safety of nizatidine in the prevention of postprandial heartburn.
    Spiegel JE; Thoden WR; Pappas K; Fratarcangelo P; Furey SA
    Arch Intern Med; 1997 Jul; 157(14):1594-9. PubMed ID: 9236562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nizatidine for the treatment of pediatric gastroesophageal reflux symptoms: an open-label, multiple-dose, randomized, multicenter clinical trial in 210 children.
    Orenstein SR; Gremse DA; Pantaleon CD; Kling DF; Rotenberg KS
    Clin Ther; 2005 Apr; 27(4):472-83. PubMed ID: 15922820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of childhood peptic esophagitis: a double-blind placebo-controlled trial of nizatidine.
    Simeone D; Caria MC; Miele E; Staiano A
    J Pediatr Gastroenterol Nutr; 1997 Jul; 25(1):51-5. PubMed ID: 9226527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D; Paré P; Pericak D; Pyzyk M;
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nizatidine and gastric emptying in functional dyspepsia.
    Koskenpato J; Punkkinen JM; Kairemo K; Färkkilä M
    Dig Dis Sci; 2008 Feb; 53(2):352-7. PubMed ID: 17682943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind, placebo-controlled, 16-week study of the H3 receptor antagonist, GSK239512 as a monotherapy in subjects with mild-to-moderate Alzheimer's disease.
    Grove RA; Harrington CM; Mahler A; Beresford I; Maruff P; Lowy MT; Nicholls AP; Boardley RL; Berges AC; Nathan PJ; Horrigan JP
    Curr Alzheimer Res; 2014 Jan; 11(1):47-58. PubMed ID: 24359500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of nizatidine, 75 mg, for the relief of episodic heartburn.
    Paul K; Redman CM; Chen M
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1571-7. PubMed ID: 11563996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of efficacy of cisapride and nizatidine in dyspepsia.
    Adelman A; Alper BS
    J Fam Pract; 1998 Jun; 46(6):457-8. PubMed ID: 9638107
    [No Abstract]   [Full Text] [Related]  

  • 11. Gastric fluid volume and pH after nizatidine in adults undergoing elective surgery: influence of timing and dose.
    Mikawa K; Nishina K; Maekawa N; Asano M; Obara H
    Can J Anaesth; 1995 Aug; 42(8):730-4. PubMed ID: 7586114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nizatidine versus placebo in active benign gastric ulcer disease: an eight-week, multicenter, randomized, double-blind comparison. The Nizatidine Benign Gastric Ulcer Disease Study Group.
    Cloud ML; Enas N; Offen WW
    Clin Pharmacol Ther; 1992 Sep; 52(3):307-13. PubMed ID: 1526089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Healing and recurrence of active duodenal ulcer with nizatidine.
    Cloud ML; Offen WW; Matsumoto C; Chernish SM
    Clin Pharmacol Ther; 1989 Sep; 46(3):310-6. PubMed ID: 2570656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzoate, a D-amino acid oxidase inhibitor, for the treatment of early-phase Alzheimer disease: a randomized, double-blind, placebo-controlled trial.
    Lin CH; Chen PK; Chang YC; Chuo LJ; Chen YS; Tsai GE; Lane HY
    Biol Psychiatry; 2014 May; 75(9):678-85. PubMed ID: 24074637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nizatidine versus placebo in gastroesophageal reflux disease: a 12-week, multicenter, randomized, double-blind study.
    Cloud ML; Offen WW; Robinson M
    Am J Gastroenterol; 1991 Dec; 86(12):1735-42. PubMed ID: 1962618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial.
    Tariot PN; Farlow MR; Grossberg GT; Graham SM; McDonald S; Gergel I;
    JAMA; 2004 Jan; 291(3):317-24. PubMed ID: 14734594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nizatidine anaphylaxis.
    Mira-Perceval JL; Ortiz JL; Sarrió F; Miralles JC; Hernández J; Negro-Alvarez JM; López-Sánchez JD; García-Sellés FJ; Pagán JA
    J Allergy Clin Immunol; 1996 Mar; 97(3):855-6. PubMed ID: 8613644
    [No Abstract]   [Full Text] [Related]  

  • 18. Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs.
    Levine LR; Cloud ML; Enas NH
    Arch Intern Med; 1993 Nov; 153(21):2449-54. PubMed ID: 8215749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nizatidine versus placebo in gastro-oesophageal reflux disease: a 12-week, multicentre, randomised, double-blind study.
    Cloud ML; Offen WW; Robinson M
    Br J Clin Pract Suppl; 1994 Nov; 76():3-10. PubMed ID: 7794701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial.
    Wilkinson D; Windfeld K; Colding-Jørgensen E
    Lancet Neurol; 2014 Nov; 13(11):1092-1099. PubMed ID: 25297016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.